IRIDEX to Report First Quarter 2018 Financial Results on May 3, 2018
April 19 2018 - 4:05PM
IRIDEX Corporation (Nasdaq:IRIX) today announced the Company will
release financial results for the first quarter 2018 after the
close of trading on Thursday, May 3, 2018. The Company’s
management team will host a corresponding conference call beginning
at 2:00 p.m. PT / 5:00 p.m. ET.
Investors interested in listening to the conference call may do
so by dialing (844) 707-0665 for domestic callers or (703) 326-3030
for international callers, using conference ID: 5495252. A
live and archived webcast of the event will be available on the
“Investors” section of the Company’s website at:
www.iridex.com. A telephone replay will also be available
beginning Thursday, May 3, 2018 through Friday, May 4, 2018 by
dialing (855) 859-2056 for domestic callers or (404) 537-3406 for
international callers, using conference ID: 5495252.
About IRIDEXIRIDEX Corporation is a worldwide
leader in developing, manufacturing, and marketing innovative and
versatile laser-based medical systems, delivery devices and
consumable instrumentation for the ophthalmology market. The
Company’s proprietary MicroPulse® technology delivers a
differentiated treatment that provides safe, effective, and proven
treatment for targeted sight-threatening eye conditions. IRIDEX’s
current product line is used for the treatment of glaucoma,
diabetic macular edema (DME) and other retinal diseases. IRIDEX
products are sold in the United States through a direct sales force
and internationally primarily through a network of independent
distributors into more than 100 countries. For further information,
visit the IRIDEX website at http://www.iridex.com/.
Investor Relations ContactLynn Pieper Lewis or
Leigh Salvo(415) 937-5404investors@iridex.com
IRIDEX (NASDAQ:IRIX)
Historical Stock Chart
From Aug 2024 to Sep 2024
IRIDEX (NASDAQ:IRIX)
Historical Stock Chart
From Sep 2023 to Sep 2024